Laurel Wealth Advisors (North Carolina)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.53M | Buy |
23,543
+197
| +0.8% | +$67.4K | 0.82% | 24 |
|
|
2026
Q1 | $7.74M | Buy |
23,346
+104
| +0.4% | +$37.1K | 0.77% | 27 |
|
|
2025
Q4 | $7.61M | Sell |
23,242
-449
| -2% | -$142K | 1.01% | 24 |
|
|
2025
Q3 | $6.69M | Sell |
23,691
-308
| -1% | -$89.3K | 0.93% | 29 |
|
|
2025
Q2 | $6.7M | Sell |
23,999
-47
| -0.2% | -$13.3K | 1% | 27 |
|
|
2025
Q1 | $7.49M | Sell |
24,046
-545
| -2% | -$161K | 1.17% | 21 |
|
|
2024
Q4 | $6.41M | Buy |
24,591
+486
| +2% | +$144K | 1% | 25 |
|
|
2024
Q3 | $7.77M | Sell |
24,105
-138
| -0.6% | -$45.1K | 1.24% | 22 |
|
|
2024
Q2 | $7.57M | Sell |
24,243
-794
| -3% | -$233K | 1.31% | 20 |
|
|
2024
Q1 | $7.12M | Sell |
25,037
-244
| -1% | -$71.4K | 1.21% | 23 |
|
|
2023
Q4 | $7.28M | Buy |
25,281
+50
| +0.2% | +$13.6K | 1.38% | 19 |
|
|
2023
Q3 | $6.78M | Sell |
25,231
-1,064
| -4% | -$266K | 1.43% | 18 |
|
|
2023
Q2 | $5.84M | Sell |
26,295
-244
| -0.9% | -$56.6K | 1.17% | 23 |
|
|
2023
Q1 | $6.42M | Buy |
26,539
+350
| +1% | +$85.9K | 1.36% | 19 |
|
|
2022
Q4 | $6.88M | Buy |
26,189
+79
| +0.3% | +$21.2K | 1.56% | 18 |
|
|
2022
Q3 | $5.88M | Buy |
26,110
+584
| +2% | +$142K | 1.47% | 19 |
|
|
2022
Q2 | $6.21M | Buy |
25,526
+125
| +0.5% | +$30.6K | 1.5% | 18 |
|
|
2022
Q1 | $6.14M | Sell |
25,401
-48
| -0.2% | -$11K | 1.29% | 22 |
|
|
2021
Q4 | $5.72M | Buy |
25,449
+880
| +4% | +$186K | 1.17% | 25 |
|
|
2021
Q3 | $5.22M | Buy |
24,569
+3,810
| +18% | +$877K | 1.15% | 24 |
|
|
2021
Q2 | $5.06M | Buy |
20,759
+982
| +5% | +$242K | 1.09% | 27 |
|
|
2021
Q1 | $4.92M | Buy |
19,777
+681
| +4% | +$162K | 1.19% | 24 |
|
|
2020
Q4 | $4.39M | Buy |
19,096
+2,393
| +14% | +$552K | 1.14% | 24 |
|
|
2020
Q3 | $4.25M | Buy |
16,703
+40
| +0.2% | +$9.91K | 1.27% | 22 |
|
|
2020
Q2 | $3.93M | Sell |
16,663
-132
| -0.8% | -$30.1K | 1.29% | 20 |
|
|
2020
Q1 | $3.4M | Buy |
16,795
+464
| +3% | +$101K | 1.28% | 20 |
|
|
2019
Q4 | $3.94M | Sell |
16,331
-335
| -2% | -$73.8K | 1.24% | 21 |
|
|
2019
Q3 | $3.23M | Sell |
16,666
-164
| -1% | -$31.5K | 1.1% | 26 |
|
|
2019
Q2 | $3.1M | Buy |
16,830
+2,042
| +14% | +$366K | 1.09% | 27 |
|
|
2019
Q1 | $2.81M | Buy |
14,788
+805
| +6% | +$154K | 1.03% | 32 |
|
|
2018
Q4 | $2.72M | Buy |
+13,983
| New | +$2.73M | 1.09% | 27 |
|
Other funds holding AMGN
Laurel Wealth Advisors (North Carolina)'s AMGN Position: Q2 2026 in Review
Laurel Wealth Advisors (North Carolina) increased its Amgen (AMGN) stake by 0.84% in Q2 2026, buying an estimated $67.4K and bringing the position to 23,543 shares worth $8.53M. The position accounts for 0.82% of the portfolio, ranked #24.
Laurel Wealth Advisors (North Carolina) first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Laurel Wealth Advisors (North Carolina) held 23,543 shares of Amgen worth $8.53M as of Q2 2026.
- Laurel Wealth Advisors (North Carolina) bought 197 Amgen shares in Q2 2026, an estimated $67.4K.
- Amgen made up 0.82% of Laurel Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #24 holding.
- Laurel Wealth Advisors (North Carolina) first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 17 Jul 2026.